Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Chemotherapy

Regeneron's Libtayo Combo Achieves Nearly Double Survival Rate In Advanced Lung Cancer Compared To Chemotherapy

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) on Tuesday announced five-year follow-up results on overall survival (OS) from the Phase 3 EMPOWER-Lung 3 trial of Libtayo (cemiplimab) plus platinum-based chemotherapy versus chemotherapy alone as a first-line treatment for adults with locally advanced or metastatic non-small cell lung cancer (NSCLC) with no EGFR, ALK,…

Benzinga

BioNTech, Bristol Myers Squibb Show Tumor Shrinkage In Lung Cancer Immunotherapy

BioNTech SE (NASDAQ:BNTX) and Bristol Myers Squibb Co (NYSE:BMY) shared interim Phase 2 data on pumitamig (BNT327/BMS986545) plus chemotherapy in patients with untreated extensive-stage small cell lung cancer (ES-SCLC).

Benzinga

AstraZeneca Lung Cancer Combo Extends Patient Survival By Years In Key Study

On Sunday, AstraZeneca Plc (AZN) released results from the final overall survival (OS) analysis of the FLAURA2 Phase 3 trial in previously untreated patients with locally advanced (Stage IIIB-IIIC) or metastatic (Stage IV) non-small cell lung cancer (NSCLC) whose tumors have EGFR exon 19 deletion or exon 21 L858R mutations.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Summit Therapeutics' Lung Cancer Drug Under Dark Clouds As Keytruda Challenger Shows Regional Data Differences

Summit Therapeutics Inc. (NASDAQ:SMMT), on Sunday, revealed the updated overall survival (OS) results from the global Phase 3 HARMONi trial of ivonescimab at the 2025 World Conference on Lung Cancer (WCLC).

Benzinga

BioNTech Advances On Positive Phase 3 Breast Cancer Drug Data

On Friday, BioNTech SE (NASDAQ:BNTX) and its partner Duality Biologics (Suzhou) Co., Ltd. released topline data from a Phase 3 trial in China evaluating trastuzumab pamirtecan (BNT323/DB-1303) versus trastuzumab emtansine (T-DM1) for HER2-positive unresectable or metastatic breast cancer patients who have previously received trastuzumab and a taxane-based chemotherapy.

Benzinga

Amgen Faces Setback As Final Data Weakens Case For Gastric Cancer Drug

On Wednesday, Amgen Inc. (NASDAQ:AMGN) and its partner Zai Lab (NASDAQ:ZLAB) said the final analysis of the Phase 3 FORTITUDE-101 trial evaluating bemarituzumab in combination with chemotherapy (mFOLFOX6) in first-line gastric cancer has been completed.

Benzinga

Dermot Murnaghan ‘feeling pretty good’ after chemotherapy for stage four cancer

The TV presenter, who has been diagnosed with prostate cancer, said men should demand testing on the NHS.

Evening Standard

Read news from The Economist, FT, and more,
with one subscription

Why do some people grow 'chemo curls' after cancer treatment?

After chemotherapy, some people get "chemo curls" and other changes to their hair texture and appearance. But why?

LiveScience

Mini hearts to save cancer survivors from heart disease

Lab-grown "mini hearts" the size of a grain of sand are being used to test new drugs researchers hope will protect breast cancer patients from heart failure.

AAP

How Designing Supercars Helped Gordon Murray Through Cancer

Gordon Murray can’t stop working. As he approaches 80 years old, Murray is still developing new supercars, and not even a cancer diagnosis took him away from the drafting table. One of Gordon Murray Automotive’s newest supercars—the S1 LM—was developed while its namesake was undergoing chemotherapy.

Motor1

Woman diagnosed with same cancer as late husband after stomach ache

Ann Lally and her late husband, Mike, were both diagnosed with advanced pancreatic cancer

The Independent UK

Parents who advised daughter against chemotherapy warned over inquest behaviour

Paloma Shemirani, 23, collapsed last July and was taken to hospital where she died five days later having earlier declined cancer treatment.

Evening Standard

Merck, Pfizer-Backed Therapy Improves Outcomes For Cisplatin-Ineligible Bladder Cancer Patients

On Tuesday, Merck Co. Inc. (NYSE:MRK) released topline results from the Phase 3 KEYNOTE-905 trial (also known as EV-303) in patients with muscle-invasive bladder cancer (MIBC) who are ineligible for cisplatin-based chemotherapy.

Benzinga

The new take-at-home drug that ‘could boost effectiveness of chemotherapy’

New medicine will spare some patients from more aggressive treatments

The Independent UK

Get all your
news in one place.

100's of premium titles.
One news app.

Evening Standard

New drug ‘could boost effectiveness of chemotherapy’, developers say

It is hoped KCL-HO-1i can be trialled on humans, with researchers suggesting it could one day be a ‘valuable companion drug’ to chemotherapy.

International Business Times

Secondhand Chemo Is Real: How Jim Mullowney Is Dealing With ChemWaste Crisis From Both People and Business Point of View

At the center of Pharma-Cycle's innovation is a patented packaging system designed to safely collect and manage human waste contaminated by chemotherapy drugs, waste that continues to emit cytotoxic chemicals long after a patient leaves the clinic.

The Fashion Central

A Mother’s Influence and a Daughter’s Death: The Story of Paloma Shemirani

A University of Cambridge graduate who tragically passed away after refusing chemotherapy for non-Hodgkin lymphoma told a court she was anti-vax

Evening Standard

Brother of woman who refused chemotherapy says mother ‘sacrificed’ her daughter

Paloma Shemirani, 23, died at Royal Sussex County Hospital on July 24 2024, after declining the treatment for non-Hodgkin lymphoma.

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

Twin brother of woman who refused chemotherapy says mother ‘sacrificed’ her daughter

Paloma Shemirani, 23, died 2024, after declining the treatment for non-Hodgkin lymphoma

Bored Panda

23YO ‘Anti-Vax’ Woman Passes Away After Refusing Chemotherapy As Brother Blames Mom

"She didn't believe she had cancer"

The Conversation

Unlocking nature’s toolkit: how plant compounds may support cancer therapy

Green tea and red wine may seem like simple dietary choices – but beneath the surface, they harbour compounds with remarkable medical potential. Scientists are uncovering how these everyday drinks might support cancer treatment, not by replacing conventional therapies like chemotherapy or radiotherapy, but by enhancing their effectiveness and reducing…

Benzinga

AstraZeneca's Multi-Billion Dollar Cancer Drug Tagrisso Improves Overall Survival In Patients With Advanced Lung Cancer

On Monday, AstraZeneca Plc (NASDAQ:AZN) released high-level results from the final overall survival (OS) analysis of the FLAURA2 Phase 3 trial of Tagrisso (osimertinib) with the addition of pemetrexed and platinum-based chemotherapy.

The Independent UK

Doctor concerned mother influenced daughter’s cancer treatment, inquest hears

Cambridge graduate Paloma Shemirani refused chemotherapy after being diagnosed in December 2023

The Guardian - UK

‘I was raped. And my dreams were shattered’ – Gina Miller on abuse, cancer and the toxic race for Cambridge chancellor

She is the activist who fought against Boris Johnson’s Brexit deal. Now she’s vying to be the university’s first female chancellor – all while going through chemotherapy. She talks about the attack that destroyed her own student years

Medical Daily

New Hodgkin's Lymphoma Treatment Boosts Fertility Preservation Without Sacrificing Survival

A new study reveals that the BrECADD chemotherapy regimen for Hodgkin's lymphoma preserves fertility far better than standard treatments—without reducing survival rates. Learn how this breakthrough is changing cancer care.

1 … 3 4 5 6

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

University of Cambridge

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.